Kaundinya Ganesh Venkataraman 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Aug 10, 2018
Insider Transaction Report
Form 4
Venkataraman Ganesh
COO & CSO
Transactions
- Exercise/Conversion
Common Stock
[F1]2018-08-08+1,410→ 496,889 total - Sale
Common Stock
[F2]2018-08-08$29.00/sh−632$18,328→ 496,257 total - Exercise/Conversion
Restricted Stock Units
[F3][F1][F4]2018-08-08−1,410→ 14,094 total→ Common Stock (1,410 underlying)
Footnotes (4)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Signature
/s/ Alejandra Carvajal as attorney in fact|2018-08-10